Travere Therapeutics Inc (TVTX)

Operating Expenses

$163.46M

Quarterly · Period ending: · USD

TVTX logo

TVTX Operating Expenses

Latest reported$163.46M
TVTX Quarterly Operating Expenses ($3.38K → $163.46M)
High-resolution chart · PNG

TVTX operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Travere Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
163,456,000
137,348,000
159,564,000
138,343,000
125,578,000
119,727,000
132,971,000
117,421,000
108,761,000
179,107,000
111,482,000
128,391,000
134,695,000
132,158,000
120,991,000
103,413,000
117,567,000
103,399,000
102,543,000
98,336,000
88,281,000
93,311,000
167,462,000
69,385,000
70,047,000
61,466,000
58,609,000
62,297,000
76,904,000
66,112,000
57,950,000
58,555,000
59,560,000
51,104,000
46,851,000
44,462,000
48,317,000
43,975,000
46,703,000
47,488,000
40,880,000
33,797,000
38,138,000
36,372,000
30,255,000
25,201,796
32,655,963
31,594,711
25,038,062
16,978,748
11,467,199
5,154,486
5,099,902
2,250,484
3,161
3,000
3,009
3,758
3,018
3,025
3,024
3,580
3,091
3,000
3,018
10,105
3,018
3,068
4,019
4,251
3,050
3,376
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.